SARG: a new human osteosarcoma cell line. Expression of bone markers and of major histocompatibility antigens

Ann Oncol. 1992 Apr:3 Suppl 2:S29-31. doi: 10.1093/annonc/3.suppl_2.s29.

Abstract

A new cell line (SARG) was established from a human radiation-induced osteosarcoma (OSA). It showed an epithelial-like morphology with polymorphous and sometimes bizarre nuclei. SARG had an osteoblastic differentiation pattern: almost 100% of the cells were positive for alkaline phosphatase, type I and III collagens and osteonectin. The expression of class I HLA antigens was detectable even after 40 in vitro passages. The expression of MHC antigens was greatly increased after in vitro treatment with interferon gamma (IFN-gamma), whereas interferon alpha (IFN-alpha) and tumor necrosis factor alpha (TNF-alpha) increased the expression of class I antigens, but not of class II antigens. SARG was tumorigenic after subcutaneous injection in nude mice. Experimental metastases were never detected.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Animals
  • Antigens, Differentiation / analysis
  • Biomarkers, Tumor / analysis*
  • Bone Neoplasms / chemistry*
  • Bone Neoplasms / immunology
  • Cytokines / pharmacology
  • HLA Antigens / analysis
  • Histocompatibility Antigens / analysis*
  • Humans
  • Male
  • Mice
  • Mice, Nude
  • Neoplasms, Radiation-Induced / chemistry*
  • Neoplasms, Radiation-Induced / immunology
  • Osteosarcoma / chemistry*
  • Osteosarcoma / immunology
  • Tumor Cells, Cultured*

Substances

  • Antigens, Differentiation
  • Biomarkers, Tumor
  • Cytokines
  • HLA Antigens
  • Histocompatibility Antigens